Navigation Links
Current Study Offers Window into Automation & Outsourcing Practices Within Top Pharmaceutical Market Research Groups
Date:2/28/2012

CHAPEL HILL, N.C., Feb. 28, 2012 /PRNewswire/ -- In an effort to maximize business impact and improve efficiency with limited resources, pharma and biotech market research leaders must constantly evaluate the manner in which they outsource their labor. More specifically, executives need to understand the optimal balance of external contract employees in order to reduce redundancy and enhance productivity in the quickly changing healthcare industry.

To identify innovative strategies and approaches for maximizing market research efficiency through the use of outsourced labor and process automation, Best Practices, LLC, a world-leader in biopharmaceutical benchmarking research, has launched an exciting new study called "Using Outsourced Personnel and Automation to Maximize Market Research Efficiency."

Preliminary results from this ongoing study suggest that outsourced labor for secondary report preparation – as compared to other key market research areas – will increase the most in the next 2-3 years.  Best Practices is also monitoring additional emerging data trends around time spent managing outsourced personnel and leading processes for enhancing the impact of offsite personnel.

Study topics include:

  • Outsourcing Profile
  • Reasons for Outsourcing
  • Outsourcing Process: Vendor Selection and Management
  • Assessing the Strategy & Value of Outsourced Market Research Labor
  • Using Automation to Expedite the Delivery of Market Research
  • Future Changes in Outsourcing Levels

This crucial research study represents the latest contribution of Best Practices, LLC to the life science industry's staffing and investment knowledge.  While previous studies have captured key metrics to identify optimal resource levels for maximum competitiveness, regulatory and other changes have continued to erode the effectiveness of the industry's proven business model - a fact pressing executives to reconsider efficient levels of human and capital investment.

This latest study therefore offers an open benchmark opportunity for market research executives throughout the bio-pharma and medical device sectors.

To view or participate in the online survey, follow this link: http://www.surveygizmo.com/s3/800600/Market-Research-Efficiency.

For assistance or questions related to this study, contact research team leader Vahid Sanii at vsanii@best-in-class.com or (919) 767-9254. Responses are requested by Mar. 9, 2012.

There is no cost to participate, and all benchmark participants will receive the complete, blinded research results and analysis for free. This study will generate comparative metrics and executive insights that participants can use in the future to help assess what outsourcing levels and automation processes are right for different sizes of company.

BEST PRACTICES, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies.

The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medical Alarm Concepts Investor Update -- News on Current Initiatives
2. Updated Survival Data from Study Comparing TTF™ (Tumor Treating Fields) Therapy to Best Standard Chemotherapy for Recurrent Glioblastoma Reported at the 16th Annual Scientific Meeting of the Society for NeuroOncology
3. Current Trends and Future Directions in Physician E-Sampling Programs for the Pharmaceutical Industry
4. Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling
5. S1P1 Agonists are Currently Indicated For Treatment of Multiple Sclerosis
6. Distinguished Speaker Dr. Elizabeth Mansfield Joins IVD Technology for Upcoming Webcast: The Regulation of Companion Diagnostics: Current Status and Updates
7. ULURU Inc. Enters Into Strategic Financings of Up to $1.6 Million at a Premium to Current Share Price
8. MedInformatix Practice Management and Electronic Medical Records Simplifies Texas Dermatology Practices Current and Future Operations
9. Groupe Athena, Inc. Provides Guidance on Current Orders
10. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
11. Assured Pharmacy Upgrades to OTC Pink Current Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... Intec Pharma Ltd. (NASDAQ: NTEC ... the appointment of Pnina Strauss-Levy as Vice ... has 15 years of experience in clinical research and ... having supported the advancement of several products through the ... the United States and Europe ...
(Date:5/2/2016)... , May 2, 2016 Kalorama Information noted ... Medical Records) market in a recent white paper.  The ... Increased physician usage, a growing market are among the ... in Kalorama,s report EMR 2016: The Market ... Kalorama,s seventh complete study of the EMR industry, and ...
(Date:5/2/2016)... 2016  Celsion Corporation (NASDAQ: CLSN ), ... from the first cohort of patients in its ... Study) combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... In the first three patients dosed, GEN-1 plus ...
Breaking Medicine Technology:
(Date:5/4/2016)... New York, NY (PRWEB) , ... May 04, ... ... nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving ... patient services – is set to return to the esteemed Quaker Ridge Golf ...
(Date:5/4/2016)... York, NY (PRWEB) , ... May 04, 2016 ... ... leading private owners, developers and operators of commercial real estate proudly announced that ... 2015 Heart Health initiative. Team members portfolio-wide will continue Olshan Properties’ annual ...
(Date:5/4/2016)... ... May 04, 2016 , ... a2z, Inc. is ... and Canadian Association for Enterostomal Therapy (CAET) will be utilizing powerful and innovative ... to attendees and exhibitors for the 2016 WOCN Society & CAET Joint Conference—which ...
(Date:5/4/2016)... ... May 04, 2016 , ... All-Star ... created to assist the people of their local community. The agency pledges to ... community leaders. Their hope is to bring awareness to important local causes with ...
(Date:5/4/2016)... East Providence, Rhode Island (PRWEB) , ... May ... ... website was launched in April 2016. SS&A teamed up with one of the ... website. This legal information portal contains informative legal articles related to the law ...
Breaking Medicine News(10 mins):